We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
+26.63%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
AUM
$10.5B
AUM Growth
+$6.2B
Cap. Flow
+$4.78B
Cap. Flow %
45.54%
Top 10 Hldgs %
28.07%
Holding
985
New
521
Increased
87
Reduced
60
Closed
171

Sector Composition

Rank Sector Weight
1 Technology 7.01%
2 Healthcare 6.25%
3 Communication Services 2.7%
4 Consumer Discretionary 2.07%
5 Financials 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOOK
776
DELISTED
HOOKIPA Pharma
HOOK
$125K ﹤0.01%
+1,123
New +$121K
LUXAW
777
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$125K ﹤0.01%
+50,000
New +$143K
UFS
778
PUT
DELISTED
DOMTAR CORPORATION (New)
UFS
$120K ﹤0.01%
+3,800
New +$108K
TEVA icon
779
PUT
Teva Pharmaceuticals
TEVA
$40.8B
$115K ﹤0.01%
11,900
BLSA
780
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$111K ﹤0.01%
+10,000
New +$107K
PDAC.WS
781
DELISTED
Peridot Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordina
PDAC.WS
$111K ﹤0.01%
+62,500
New +$90.3K
LOKB.U
782
DELISTED
Live Oak Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-th
LOKB.U
$109K ﹤0.01%
+10,000
New +$105K
VIHAU
783
DELISTED
VPC Impact Acquisition Holdings Unit
VIHAU
$107K ﹤0.01%
10,000
SNPR.WS
784
DELISTED
Tortoise Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary shar
SNPR.WS
$107K ﹤0.01%
+37,500
New +$84.8K
LNFA.U
785
DELISTED
L&F Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one rede
LNFA.U
$104K ﹤0.01%
+10,000
New +$102K
VYGG.WS
786
DELISTED
Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
VYGG.WS
$103K ﹤0.01%
+50,000
New +$90.7K
NTES icon
787
CALL
NetEase
NTES
$85.3B
$96K ﹤0.01%
+1,000
New +$89.7K
NTES icon
788
PUT
NetEase
NTES
$85.3B
$96K ﹤0.01%
+1,000
New +$89.7K
VMW
789
DELISTED
VMware, Inc
VMW
$93K ﹤0.01%
666
PTRAW
790
DELISTED
Proterra Inc. Warrant
PTRAW
$86K ﹤0.01%
+37,500
New +$66.6K
TEVA icon
791
CALL
Teva Pharmaceuticals
TEVA
$40.8B
$82K ﹤0.01%
8,500
AJAX.WS
792
DELISTED
Capri Listco Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exer
AJAX.WS
$82K ﹤0.01%
+25,000
New +$80K
RTP.WS
793
DELISTED
Reinvent Technology Partners Redeemable Warrants, each whole warrant exercisable for one Class A ord
RTP.WS
$81K ﹤0.01%
+25,000
New +$67.6K
JPM icon
794
CALL
JPMorgan Chase
JPM
$935B
$76K ﹤0.01%
600
-2,500
-81% -$279K
VALE icon
795
CALL
Vale
VALE
$64.1B
$74K ﹤0.01%
+4,400
New +$58.6K
SPNV.WS
796
DELISTED
Supernova Partners Acquisition Company, Inc. Warrants, each whole warrant exercisable for one share
SPNV.WS
$68K ﹤0.01%
+33,333
New +$74.8K
ELMSW
797
DELISTED
Electric Last Mile Solutions, Inc. Warrant
ELMSW
$58K ﹤0.01%
+16,666
New +$33.6K
FCX icon
798
CALL
Freeport-McMoran
FCX
$90B
$57K ﹤0.01%
2,200
ALXN
799
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
$47K ﹤0.01%
+300
New +$38.5K
OPK icon
800
PUT
Opko Health
OPK
$985M
$46K ﹤0.01%
+11,600
New +$48.4K

Similar funds

CAAS Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, CAAS Capital Management held 985 positions worth $10.5B, up 145% from $4.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

CAAS Capital Management deployed $4.78B of net new capital in Q4 2020, opening 521 new positions and adding to 87 existing holdings. Its largest new stake was Sunrun: 1,519,346 shares worth $105M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.8% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was First Solar, an estimated $71.8M trimmed.

  • CAAS Capital Management's largest Q4 2020 buy was Sunrun: 1,519,346 shares worth $105M.
  • CAAS Capital Management added most to Royalty Pharma in Q4 2020, an estimated $153M increase.
  • CAAS Capital Management's biggest Q4 2020 reduction was First Solar, cutting an estimated $71.8M.
  • CAAS Capital Management fully exited 10x Genomics in Q4 2020, selling an estimated $62.3M.
  • CAAS Capital Management's ten largest holdings make up 28% of its $10.5B portfolio in Q4 2020.
  • CAAS Capital Management opened 521 new positions and closed 171 in Q4 2020.
  • CAAS Capital Management's portfolio value rose 145% quarter-over-quarter to $10.5B.

Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.